| Literature DB >> 34560242 |
P G Casali1, J Y Blay2, N Abecassis3, J Bajpai4, S Bauer5, R Biagini6, S Bielack7, S Bonvalot8, I Boukovinas9, J V M G Bovee10, K Boye11, T Brodowicz12, A Buonadonna13, E De Álava14, A P Dei Tos15, X G Del Muro16, A Dufresne17, M Eriksson18, A Fedenko19, V Ferraresi20, A Ferrari21, A M Frezza22, S Gasperoni23, H Gelderblom24, F Gouin25, G Grignani26, R Haas27, A B Hassan28, N Hindi29, P Hohenberger30, H Joensuu31, R L Jones32, C Jungels33, P Jutte34, B Kasper30, A Kawai35, K Kopeckova36, D A Krákorová37, A Le Cesne38, F Le Grange39, E Legius40, A Leithner41, A Lopez-Pousa42, J Martin-Broto29, O Merimsky43, C Messiou44, A B Miah45, O Mir46, M Montemurro47, C Morosi48, E Palmerini49, M A Pantaleo50, R Piana51, S Piperno-Neumann52, P Reichardt53, P Rutkowski54, A A Safwat55, C Sangalli56, M Sbaraglia15, S Scheipl41, P Schöffski57, S Sleijfer58, D Strauss59, S J Strauss39, K Sundby Hall11, A Trama60, M Unk61, M A J van de Sande62, W T A van der Graaf63, W J van Houdt64, T Frebourg65, A Gronchi66, S Stacchiotti22.
Abstract
Entities:
Keywords: GIST; clinical practice guidelines; gastrointestinal stromal tumour; surgery; tyrosine kinase inhibitor
Mesh：
Year: 2021 PMID： 34560242 DOI： 10.1016/j.annonc.2021.09.005
Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976